| Adjusted hazard ratio | 95% confidence interval | P value |
---|---|---|---|
Male | 2.41 | 0.75 – 7.72 | 0.139 |
Age | 1.05 | 0.99 – 1.1 | 0.102 |
Comorbidity | Â | Â | Â |
 Human immunodeficiency virus infection | - | - | - |
 Chronic obstructive pulmonary disease | 0.77 | 0.09 – 6.36 | 0.809 |
 Connective tissue disease | 0.36 | 0.08- 1.65 | 0.189 |
 Silicosis | - | - | - |
 Diabetes mellitus | 2.01 | 0.67 – 6.06 | 0.216 |
 End stage renal disease | 1.97 | 0.25 – 15.63 | 0.522 |
 Malignancy | 0.99 | 0.11 – 8.58 | 0.993 |
Liver disease | Â | Â | Â |
 Non-alcoholic liver cirrhosis | 1.48 | 0.30 – 7.40 | 0.631 |
 Alcoholic liver cirrhosis | - | - | - |
 Other alcoholic liver disease | - | - | - |
Liver disease severity | Â | Â | Â |
 Ascites | - | - | - |
 Esophageal varices | - | - | - |
 Hepatic encephalopathy | 16.75 | 1.22 – 231.02 | *0.035 |
Interferon-based therapy | 1.02 | 0.28 – 3.78 | 0.974 |